MedPath

Comparing the effect of Urtica Dioica with mefenamic acid on heavy menstrual bleeding.

Phase 3
Conditions
Menorrhagia.
??????? ???? ?????? ?? ??????? ????.
Registration Number
IRCT201111254529N3
Lead Sponsor
International part Of Shahid Beheshti University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Age15 to 45 years; Body Mass Index 18.5 to 29.9; Being affected by menorrhagia, distinguished by using pictorial blood loss assessment chart. exclusion criteria: Having an special disease; pregnancy or deciding to be pregnant in three future month; berestfeeding; allergy to urtica dioica; dont follow the exact priscribed curing method; patient,s tendency to going out of study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of days of bleeding in menstruation. Timepoint: Befor, one month and then two month after intervention. Method of measurement: By using pictorial blood loss assessmant chart.;Amount of menstrual Bleeding. Timepoint: Befor, one month and two month after intervention. Method of measurement: By using pictorial blood loss assessmant chart.
Secondary Outcome Measures
NameTimeMethod
Side effects of priscribed drugs. Timepoint: During and after first and second month of using drugs. Method of measurement: By using the chart of daily using of drugs.
© Copyright 2025. All Rights Reserved by MedPath